Wolverine Blend – BPC-157 (5mg) / TB500 (5mg)

Tissue repair & regeneration – In preclinical laboratory models, BPC-157 enhances fibroblast functionality, upregulates growth factor receptor expression and promotes angiogenesis (formation of new blood vessels) via pathways such as VEGF and NO. Meanwhile, the Thymosin β4 fragment supports cell migration, actin-filament formation and movement of repair cells to injury sites. When used in combination, these peptides may offer synergistic effects: BPC-157 improving cellular environment and vascular supply; the TB fragment improving cell mobilization to damaged tissue.

Anti-inflammatory & protective signaling – BPC-157 has been shown to modulate inflammatory signaling (e.g., via NO, cytokine pathways) and support gastrointestinal, neural and vascular tissue under stress. The Thymosin β4 fragment may further assist by reducing scaffolding-damage, improving extracellular matrix reorganization and promoting vascular regeneration.

Research considerations – These benefits are primarily based on rodent/animal models and in vitro studies. No large-scale human clinical trials exist for this specific blend.
Intended research applications include tendon/ligament healing, muscle recovery, vascular injury repair and possibly neuro-vascular regeneration.

Legal Disclaimer & Safety Information

This blend is for research use only. It is not approved for human consumption, treatment or dietary supplementation. Keep out of reach of children. Use only in controlled laboratory settings by qualified personnel. The supplier attests to purity and identity but makes no claims of therapeutic benefit.